Bragar Eagel & Squire, P.C. Is Investigating TrueBlue, NeoGenomics, GoodRx, and Ebix and Encourages Investors to Contact the Firm

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.